Mesenchymal lesions of the breast

Mesenchymal lesions of the breast are a heterogeneous range of entities with diverse clinical, histological, and molecular features, as well as biological behaviour. Their morphologic overlap with non‐mesenchymal lesions (such as metaplastic carcinoma and phyllodes tumour) and relative rarity also pose significant diagnostic challenges. In this review, we summarize the salient features of selected mesenchymal lesions of the breast, emphasizing those that are the most common and problematic. Vascular, fibroblastic/myofibroblastic, adipocytic, and smooth muscle lesions are each covered with regard to their clinicopathological features and differential diagnosis, while recent advances and the role of immunohistochemistry and molecular tests are also highlighted.

[1]  E. Brogi,et al.  Spindle cell lesions of the breast: a diagnostic approach , 2021, Virchows Archiv.

[2]  Ryanne A. Brown,et al.  Nodular fasciitis of the breast: clinicopathologic and molecular characterization with identification of novel USP6 fusion partners , 2021, Modern Pathology.

[3]  F. Khan,et al.  Myofibroblastic stromal hyperplasia of the breast , 2021, Modern Pathology.

[4]  P. Terrier,et al.  Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast , 2020, The American journal of surgical pathology.

[5]  T. Molina,et al.  Soft tissue angiomatosis: another PIK3CA‐related disorder , 2020, Histopathology.

[6]  I. Nagtegaal,et al.  Assessment of Radiotherapy-Associated Angiosarcoma After Breast Cancer Treatment in a Dutch Population-Based Study , 2019, JAMA oncology.

[7]  C. Rubino,et al.  The Influence of Breast Cancer on the Distribution of Cherry Angiomas on the Anterior Thoracic Wall: A Case Series Study , 2018, Dermatology.

[8]  C. Antonescu,et al.  Dermatofibrosarcoma protuberans with a novel COL6A3‐PDGFD fusion gene and apparent predilection for breast , 2018, Genes, chromosomes & cancer.

[9]  F. Mertens,et al.  Frequent low‐level mutations of protein kinase D2 in angiolipoma , 2017, The Journal of pathology.

[10]  S. Fineberg,et al.  Core Biopsy of Vascular Neoplasms of the Breast: Pathologic Features, Imaging, and Clinical Findings , 2016, The American journal of surgical pathology.

[11]  Narasimhan P. Agaram,et al.  Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations , 2016, The American journal of surgical pathology.

[12]  C. Fletcher,et al.  Mammary-type Myofibroblastoma: Clinicopathologic Characterization in a Series of 143 Cases , 2016, The American journal of surgical pathology.

[13]  Dafydd G. Thomas,et al.  Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well‐differentiated Liposarcoma of Soft Tissue , 2016, The breast journal.

[14]  M. Sanders,et al.  Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification , 2016, Histopathology.

[15]  A. Degnim,et al.  Diffuse dermal angiomatosis of the breast: a series of 22 cases from a single institution. , 2015, Gland surgery.

[16]  B. Clark,et al.  Low-grade fibromatosis-like spindle cell carcinoma of the breast. , 2015, Archives of pathology & laboratory medicine.

[17]  F. Mertens,et al.  Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics , 2014, Modern Pathology.

[18]  J. Hornick,et al.  SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours , 2013, Histopathology.

[19]  I. Ellis,et al.  Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours. , 2013, Breast.

[20]  C. Fletcher,et al.  Loss of Retinoblastoma Protein Expression in Spindle Cell/Pleomorphic Lipomas and Cytogenetically Related Tumors: An Immunohistochemical Study With Diagnostic Implications , 2012, The American journal of surgical pathology.

[21]  M. Chou,et al.  Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion , 2011, Laboratory Investigation.

[22]  N. Gupta,et al.  Angiolipoma of the Female Breast: Clinicomorphological Correlation of 52 Cases , 2011, International journal of surgical pathology.

[23]  C. Antonescu,et al.  Consistent MYC and FLT4 gene amplification in radiation‐induced angiosarcoma but not in other radiation‐associated atypical vascular lesions , 2011, Genes, chromosomes & cancer.

[24]  I. Ellis,et al.  β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast , 2010, Modern Pathology.

[25]  C. Raut,et al.  Primary Angiosarcoma of the Breast: Clinicopathologic Analysis of 49 Cases, Suggesting That Grade is not Prognostic , 2008, The American journal of surgical pathology.

[26]  A. Lazar,et al.  Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. , 2008, The American journal of pathology.

[27]  C. Fletcher,et al.  Immunohistochemistry for β‐catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature , 2007 .

[28]  L. Guillou,et al.  Vascular proliferations of the skin after radiation therapy for breast cancer: Clinicopathologic analysis of a series in favor of a benign process , 2007, Cancer.

[29]  C. Fletcher,et al.  Spindle Cell (Sarcomatoid) Carcinoma of the Breast: A Clinicopathologic and Immunohistochemical Analysis of 29 Cases , 2006, The American journal of surgical pathology.

[30]  Louis Guillou,et al.  MDM2 and CDK4 Immunostainings Are Useful Adjuncts in Diagnosing Well-Differentiated and Dedifferentiated Liposarcoma Subtypes: A Comparative Analysis of 559 Soft Tissue Neoplasms With Genetic Data , 2005, The American journal of surgical pathology.

[31]  C. Fletcher,et al.  Radiation-Associated Cutaneous Atypical Vascular Lesions and Angiosarcoma: Clinicopathologic Analysis of 42 Cases , 2005, The American journal of surgical pathology.

[32]  J. Simpson,et al.  Metaplastic breast tumors with a dominant fibromatosis‐like phenotype have a high risk of local recurrence , 1999, Cancer.

[33]  J. Keller,et al.  Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases. , 1998, The American journal of surgical pathology.

[34]  J. Dumanski,et al.  Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell fibroblastoma , 1997, Nature Genetics.

[35]  M. Cranor,et al.  Pseudoangiomatous Stromal Hyperplasia (PASH): A Mammary Stromal Tumor with Myofibroblastic Differentiation , 1995, The American journal of surgical pathology.

[36]  S. Fineberg,et al.  Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma. , 1994, American journal of clinical pathology.

[37]  C. Fletcher,et al.  Sinusoidal Hemangioma: A Distinctive Benign Vascular Neoplasm Within the Group of Cavernous Hemangiomas , 1991, The American journal of surgical pathology.

[38]  S. Weiss,et al.  Myofibroblastoma of the Breast: Sixteen Cases of a Distinctive Benign Mesenchymal Tumor , 1987, The American journal of surgical pathology.

[39]  R. Erlandson,et al.  Pseudoangiomatous hyperplasia of mammary stroma. , 1986, Human pathology.

[40]  R. Brown,et al.  Incidence of perilobular hemangioma in the female breast. , 1983, Archives of pathology & laboratory medicine.

[41]  K. Hunt,et al.  Angiosarcoma of the breast , 2005, Cancer.

[42]  P. Rosen,et al.  Leiomyoma of the nipple , 1979, The American journal of surgical pathology.

[43]  P. Rosen,et al.  The perilobular hemangioma. A benign microscopic vascular lesion of the breast. , 1977, American journal of clinical pathology.

[44]  B. E. Konwaler,et al.  Subcutaneous pseudosarcomatous fibromatosis (fasciitis). , 1955, American journal of clinical pathology.